File Download
Supplementary
- Citations:
- Appears in Collections:
Article: Blockade of the renin-angiotensin system
Title | Blockade of the renin-angiotensin system |
---|---|
Authors | |
Keywords | Angiotensin II Angiotensin-converting enzyme inhibitors Hypertension |
Issue Date | 2002 |
Publisher | Hong Kong Medical Association. The Journal's web site is located at http://www.hkmj.org/resources/supp.html |
Citation | Hong Kong Medical Journal, 2002, v. 8 n. 3, p. 185-191 How to Cite? |
Abstract | The renin-angiotensin-aldosterone system plays a key role in the regulation of fluid and electrolyte balance. Angiotensin-converting enzyme inhibitors inhibit angiotensin-converting enzyme and have been shown to be effective in many cardiovascular diseases. They should be considered for the treatment of hypertension in patients with heart failure, previous myocardial infarction, diabetes, or proteinuria. There are a number of side-effects associated with angiotensin-converting enzyme inhibitors, especially persistent dry cough. Angiotensin II receptor antagonists (sartans) provide a more specific blockade of the renin-angiotensin-aldosterone system and are associated with fewer side-effects, including cough. Their long-term efficacy and tolerability in the treatment of patients with hypertension has, however, yet to be established. Periodic monitoring of renal function and electrolytes is required in patients treated with an angiotensin-converting enzyme inhibitor or a sartan. |
Persistent Identifier | http://hdl.handle.net/10722/45121 |
ISSN | 2023 Impact Factor: 3.1 2023 SCImago Journal Rankings: 0.261 |
References |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Cheung, BMY | en_HK |
dc.date.accessioned | 2007-10-30T06:17:50Z | - |
dc.date.available | 2007-10-30T06:17:50Z | - |
dc.date.issued | 2002 | en_HK |
dc.identifier.citation | Hong Kong Medical Journal, 2002, v. 8 n. 3, p. 185-191 | en_HK |
dc.identifier.issn | 1024-2708 | en_HK |
dc.identifier.uri | http://hdl.handle.net/10722/45121 | - |
dc.description.abstract | The renin-angiotensin-aldosterone system plays a key role in the regulation of fluid and electrolyte balance. Angiotensin-converting enzyme inhibitors inhibit angiotensin-converting enzyme and have been shown to be effective in many cardiovascular diseases. They should be considered for the treatment of hypertension in patients with heart failure, previous myocardial infarction, diabetes, or proteinuria. There are a number of side-effects associated with angiotensin-converting enzyme inhibitors, especially persistent dry cough. Angiotensin II receptor antagonists (sartans) provide a more specific blockade of the renin-angiotensin-aldosterone system and are associated with fewer side-effects, including cough. Their long-term efficacy and tolerability in the treatment of patients with hypertension has, however, yet to be established. Periodic monitoring of renal function and electrolytes is required in patients treated with an angiotensin-converting enzyme inhibitor or a sartan. | en_HK |
dc.format.extent | 240772 bytes | - |
dc.format.extent | 630306 bytes | - |
dc.format.extent | 12429 bytes | - |
dc.format.mimetype | application/pdf | - |
dc.format.mimetype | application/pdf | - |
dc.format.mimetype | text/plain | - |
dc.language | eng | en_HK |
dc.publisher | Hong Kong Medical Association. The Journal's web site is located at http://www.hkmj.org/resources/supp.html | en_HK |
dc.relation.ispartof | Hong Kong Medical Journal | en_HK |
dc.rights | This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. | - |
dc.subject | Angiotensin II | en_HK |
dc.subject | Angiotensin-converting enzyme inhibitors | en_HK |
dc.subject | Hypertension | en_HK |
dc.subject.mesh | Angiotensin-Converting Enzyme Inhibitors - adverse effects - pharmacology - therapeutic use | en_HK |
dc.subject.mesh | Cardiovascular Diseases - drug therapy - physiopathology | en_HK |
dc.subject.mesh | Renin-Angiotensin System - drug effects | en_HK |
dc.subject.mesh | Diabetic Nephropathies - drug therapy | en_HK |
dc.subject.mesh | Hypertension - drug therapy | en_HK |
dc.title | Blockade of the renin-angiotensin system | en_HK |
dc.type | Article | en_HK |
dc.identifier.openurl | http://library.hku.hk:4550/resserv?sid=HKU:IR&issn=1024-2708&volume=8&issue=3&spage=185&epage=191&date=2002&atitle=Blockade+of+the+renin-angiotensin+system | en_HK |
dc.identifier.email | Cheung, BMY:mycheung@hku.hk | en_HK |
dc.identifier.authority | Cheung, BMY=rp01321 | en_HK |
dc.description.nature | published_or_final_version | en_HK |
dc.identifier.pmid | 12055364 | - |
dc.identifier.scopus | eid_2-s2.0-0036080831 | en_HK |
dc.identifier.hkuros | 70047 | - |
dc.relation.references | http://www.scopus.com/mlt/select.url?eid=2-s2.0-0036080831&selection=ref&src=s&origin=recordpage | en_HK |
dc.identifier.volume | 8 | en_HK |
dc.identifier.issue | 3 | en_HK |
dc.identifier.spage | 185 | en_HK |
dc.identifier.epage | 191 | en_HK |
dc.publisher.place | Hong Kong | en_HK |
dc.identifier.scopusauthorid | Cheung, BMY=7103294806 | en_HK |
dc.identifier.issnl | 1024-2708 | - |